Risk factors for toxoplasmosis in people living with HIV in the Asia-Pacific region
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0306245 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Ki Hyun Lee und 23 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine and AIDS Research Institute, Yonsei University College of Medicine, Seoul, South Korea. Hauptthemen laut MEDLINE: Toxoplasmosis, HIV Infections. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS.
Abstract (Originalsprache)
Introduction
Toxoplasma gondii can cause symptomatic toxoplasmosis in immunodeficient hosts, including in people living with human immunodeficiency virus (PLWH), mainly because of the reactivation of latent infection. We assessed the prevalence of toxoplasmosis and its associated risk factors in PLWH in the Asia-Pacific region using data from the TREAT Asia Human Immunodeficiency Virus (HIV) Observational Database (TAHOD) of the International Epidemiology Databases to Evaluate AIDS (IeDEA) Asia-Pacific.
Methods
This study included both retrospective and prospective cases of toxoplasmosis reported between 1997 and 2020. A matched case-control method was employed, where PLWH diagnosed with toxoplasmosis (cases) were each matched to two PLWH without a toxoplasmosis diagnosis (controls) from the same site. Sites without toxoplasmosis were excluded. Risk factors for toxoplasmosis were analyzed using conditional logistic regression.
Results
A total of 269/9576 (2.8%) PLWH were diagnosed with toxoplasmosis in 19 TAHOD sites. Of these, 227 (84%) were reported retrospectively and 42 (16%) were prospective diagnoses after cohort enrollment. At the time of toxoplasmosis diagnosis, the median age was 33 years (interquartile range 28–38), and 80% participants were male, 75% were not on antiretroviral therapy (ART). Excluding 63 out of 269 people without CD4 values, 192 (93.2%) had CD4 ≤200 cells/μL and 162 (78.6%) had CD4 ≤100 cells/μL. By employing 538 matched controls, we found that factors associated with toxoplasmosis included abstaining from ART (odds ratio [OR] 3.62, 95% CI 1.81–7.24), in comparison to receiving nucleoside reverse transcriptase inhibitors plus non-nucleoside reverse transcriptase inhibitors, HIV exposure through injection drug use (OR 2.27, 95% CI 1.15–4.47) as opposed to engaging in heterosexual intercourse and testing positive for hepatitis B virus surface antigen (OR 3.19, 95% CI 1.41–7.21). Toxoplasmosis was less likely with increasing CD4 counts (51–100 cells/μL: OR 0.41, 95% CI 0.18–0.96; 101–200 cells/μL: OR 0.14, 95% CI 0.06–0.34; >200 cells/μL: OR 0.02, 95% CI 0.01–0.06), when compared to CD4 ≤50 cells/μL. Moreover, the use of prophylactic cotrimoxazole was not associated with toxoplasmosis.
Conclusions
Symptomatic toxoplasmosis is rare but still occurs in PLWH in the Asia-Pacific region, especially in the context of delayed diagnosis, causing advanced HIV disease. Immune reconstitution through early diagnosis and ART administration remains a priority in Asian PLWH.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Internal Medicine and AIDS Research Institute, Yonsei University College of Medicine, Seoul, South Korea.
- The Kirby Institute, UNSW Sydney, Kensington, New South Wales, Australia.
- Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
- BJ Government Medical College and Sassoon General Hospital, Pune, India.
- National Center for HIV/AIDS, Dermatology & STDs, Phnom Penh, Cambodia.
- Faculty of Medicine Universitas Indonesia - Dr. Cipto Mangunkusumo General Hospital, Jakarta, Indonesia.
ORCID-Profile: Ki Hyun Lee, Suwimon Khusuwan, Junko Tanuma, Jun Yong Choi
Förderung
- NIAID NIH HHS
Zitieren
APA
Lee, K. H., Jiamsakul, A., Kiertiburanakul, S., Borse, R., Khol, V., Yunihastuti, E., Azwa, I., Somia, I. K. A., Chaiwarith, R., Pham, T. N., Khusuwan, S., Do, C. D., Kumarasamy, N., Gani, Y., Ditangco, R., Ng, O. T., Pujari, S., Lee, M. P., Avihingsanon, A., …, & Choi, J. Y. (2024). Risk factors for toxoplasmosis in people living with HIV in the Asia-Pacific region. PLOS ONE. https://doi.org/10.1371/journal.pone.0306245
Vancouver
Lee KH, Jiamsakul A, Kiertiburanakul S, Borse R, Khol V, Yunihastuti E, et al. Risk factors for toxoplasmosis in people living with HIV in the Asia-Pacific region. PLOS ONE. 2024. doi:10.1371/journal.pone.0306245
BibTeX
@article{Lee2024,
author = {Lee, Ki Hyun and Jiamsakul, Awachana and Kiertiburanakul, Sasisopin and Borse, Rohidas and Khol, Vohith and Yunihastuti, Evy and Azwa, Iskandar and Somia, I Ketut Agus and Chaiwarith, Romanee and Pham, Thach Ngoc and Khusuwan, Suwimon and Do, Cuong Duy and Kumarasamy, Nagalingeswaran and Gani, Yasmin and Ditangco, Rossana and Ng, Oon Tek and Pujari, Sanjay and Lee, Man Po and Avihingsanon, Anchalee and Chen, Hsin-Pai and Zhang, Fujie and Tanuma, Junko and Ross, Jeremy and Choi, Jun Yong},
title = {Risk factors for toxoplasmosis in people living with HIV in the Asia-Pacific region},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0306245}
}
EUVIMED